Sanofi Stock Euronext Paris
Stocks
SANNV
FR0014013QA3
Pharmaceuticals
OTC Markets Traded| Market Cap | 90.33B 104B 84.57B 77.16B 145B 9,942B 148B 992B 389B 4,976B 391B 383B 16,602B | P/E 2026 * |
12x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 95.25B 86.91B 164B 11,199B 166B 1,117B 438B 5,605B 441B 431B 18,700B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.95x |
| Free-Float |
88.34% | Yield 2026 * |
5.64% | Yield 2027 * | 5.97% |
Last Transcript: Sanofi
| 1 day | +6.12% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 11/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.12% | -1.27% | - | - | 104B | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.50% | -0.30% | +47.56% | +37.29% | 363B | |
| -1.68% | -0.50% | +28.69% | +36.21% | 295B | |
| -1.22% | -2.74% | +5.59% | +5.33% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| -3.44% | +1.19% | -7.08% | -51.91% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | -0.24% | +2.88% | +33.27% | +44.25% | 406.57B | |
| Weighted average by Cap. | -0.41% | +4.29% | +48.97% | +65.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.51B 54.82B 44.47B 40.58B 76.36B 5,229B 77.65B 521B 204B 2,617B 206B 201B 8,731B | 50.61B 58.4B 47.38B 43.23B 81.35B 5,570B 82.72B 556B 218B 2,788B 219B 214B 9,301B |
| Net income | 7.94B 9.16B 7.43B 6.78B 12.76B 874B 12.98B 87.17B 34.15B 437B 34.41B 33.66B 1,459B | 9.27B 10.69B 8.68B 7.92B 14.9B 1,020B 15.15B 102B 39.86B 511B 40.15B 39.28B 1,703B |
| Net Debt | 11.42B 13.17B 10.69B 9.75B 18.35B 1,256B 18.66B 125B 49.09B 629B 49.46B 48.38B 2,098B | 8.23B 9.5B 7.71B 7.03B 13.23B 906B 13.46B 90.37B 35.41B 454B 35.67B 34.89B 1,513B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
